296 related articles for article (PubMed ID: 9100677)
1. The role of axillary dissection in mammographically detected carcinoma.
Pandelidis SM; Peters KL; Walusimbi MS; Casady RL; Laux SV; Cavanaugh SH; Bauer TL
J Am Coll Surg; 1997 Apr; 184(4):341-5. PubMed ID: 9100677
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
3. Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequential.
Schwartz GF; Carter DL; Conant EF; Gannon FH; Finkel GC; Feig SA
Cancer; 1994 Mar; 73(6):1660-5. PubMed ID: 8156493
[TBL] [Abstract][Full Text] [Related]
4. [Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma].
Berclaz G; Crazzolara AO; Altermatt HJ; Aebi S; Fey MF; Hänggi W; Dreher E
Schweiz Med Wochenschr; 1998 Oct; 128(44):1730-6. PubMed ID: 9846346
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
6. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
7. Primary tumour characteristics and axillary lymph node status in breast cancer.
Yiangou C; Shousha S; Sinnett HD
Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
10. Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?
Saiz E; Toonkel R; Poppiti RJ; Robinson MJ
Cancer; 1999 May; 85(10):2206-11. PubMed ID: 10326699
[TBL] [Abstract][Full Text] [Related]
11. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
12. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?
Heimann R; Munsell M; McBride R
Cancer J; 2002; 8(3):276-81. PubMed ID: 12074328
[TBL] [Abstract][Full Text] [Related]
13. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
[TBL] [Abstract][Full Text] [Related]
14. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy.
Bauer TL; Pandelidis SM; Rhoads JE
J Am Coll Surg; 1994 May; 178(5):427-30. PubMed ID: 8167877
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
Silverstein MJ; Gierson ED; Waisman JR; Senofsky GM; Colburn WJ; Gamagami P
Cancer; 1994 Feb; 73(3):664-7. PubMed ID: 8299088
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.
Giuliano AE; Barth AM; Spivack B; Beitsch PD; Evans SW
J Am Coll Surg; 1996 Sep; 183(3):185-9. PubMed ID: 8784309
[TBL] [Abstract][Full Text] [Related]
17. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
19. T1a and T1b breast cancer: a twelve-year experience.
Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
[TBL] [Abstract][Full Text] [Related]
20. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.
Fein DA; Fowble BL; Hanlon AL; Hooks MA; Hoffman JP; Sigurdson ER; Jardines LA; Eisenberg BL
J Surg Oncol; 1997 May; 65(1):34-9. PubMed ID: 9179265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]